Literature DB >> 21447377

Cyclosporin A--a review on fermentative production, downstream processing and pharmacological applications.

Shrikant A Survase1, Lalit D Kagliwal, Uday S Annapure, Rekha S Singhal.   

Abstract

In present times, the immunosuppressants have gained considerable importance in the world market. Cyclosporin A (CyA) is a cyclic undecapeptide with a variety of biological activities including immunosuppressive, anti-inflammatory, antifungal and antiparasitic properties. CyA is produced by various types of fermentation techniques using Tolypocladium inflatum. In the present review, we discuss the biosynthetic pathway, fermentative production, downstream processing and pharmacological activities of CyA.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447377     DOI: 10.1016/j.biotechadv.2011.03.004

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  22 in total

Review 1.  Peptidomimetic therapeutics: scientific approaches and opportunities.

Authors:  Nir Qvit; Samuel J S Rubin; Travis J Urban; Daria Mochly-Rosen; Eric R Gross
Journal:  Drug Discov Today       Date:  2016-11-14       Impact factor: 7.851

2.  Chemical mutagenesis and high throughput media optimization in Tolypocladium inflatum MTCC-3538 leads to enhanced production of cyclosporine A.

Authors:  Vidushi Abrol; Manoj Kushwaha; Sharada Mallubhotla; Sundeep Jaglan
Journal:  3 Biotech       Date:  2022-07-05       Impact factor: 2.893

Review 3.  Subcellular localization of fungal specialized metabolites.

Authors:  Elizabeth Skellam
Journal:  Fungal Biol Biotechnol       Date:  2022-05-25

Review 4.  Tolypocladamide H and the Proposed Tolypocladamide NRPS in Tolypocladium Species.

Authors:  Richard M Tehan; Rheannon R Blount; Ryan L Goold; Daphne R Mattos; Nicolas R Spatafora; Javier F Tabima; Romina Gazis; Chengshu Wang; Jane E Ishmael; Joseph W Spatafora; Kerry L McPhail
Journal:  J Nat Prod       Date:  2022-05-02       Impact factor: 4.803

5.  Discovery of cryptic polyketide metabolites from dermatophytes using heterologous expression in Aspergillus nidulans.

Authors:  Wen-Bing Yin; Yit Heng Chooi; Adam R Smith; Ralph A Cacho; Youcai Hu; Theodore C White; Yi Tang
Journal:  ACS Synth Biol       Date:  2013-06-11       Impact factor: 5.110

6.  Cyclophilin A Plays Potential Roles in a Rat Model of Asthma and Suppression of Immune Response.

Authors:  Cai-Tao Chen; Chun-Xiao Shan; Jun Ran; Lei-Miao Yin; Hai-Yan Li; Yu Wang; Yu-Dong Xu; Jing-Lei Guo; Yang-Lin Shi; Yan-Jiao Chen; Yong-Qing Yang
Journal:  J Asthma Allergy       Date:  2021-05-07

7.  Analysis of Molecular Interactions between Components in Phospholipid-Immunosuppressant-Antioxidant Mixed Langmuir Films.

Authors:  Małgorzata Jurak; Klaudia Szafran; Pilar Cea; Santiago Martín
Journal:  Langmuir       Date:  2021-04-29       Impact factor: 3.882

Review 8.  Immunomodulation on the ocular surface: a review.

Authors:  Anna M Ambroziak; Jerzy Szaflik; Jacek P Szaflik; Maciej Ambroziak; Jan Witkiewicz; Piotr Skopiński
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

9.  Phylogenetic-based nomenclatural proposals for Ophiocordycipitaceae (Hypocreales) with new combinations in Tolypocladium.

Authors:  C Alisha Quandt; Ryan M Kepler; Walter Gams; João P M Araújo; Sayaka Ban; Harry C Evans; David Hughes; Richard Humber; Nigel Hywel-Jones; Zengzhi Li; J Jennifer Luangsa-Ard; Stephen A Rehner; Tatiana Sanjuan; Hiroki Sato; Bhushan Shrestha; Gi-Ho Sung; Yi-Jian Yao; Rasoul Zare; Joseph W Spatafora
Journal:  IMA Fungus       Date:  2014-06-19       Impact factor: 3.515

10.  Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.

Authors:  Melissa Guada; Victor Sebastián; Silvia Irusta; Esperanza Feijoó; María del Carmen Dios-Viéitez; María José Blanco-Prieto
Journal:  Int J Nanomedicine       Date:  2015-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.